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guideline and the shortly coming updated version is an appropriate time to review
and compare it with other European guidelines in order to identify the main sim-
ilarities and differences in key features. METHODS: We chose 14 European guide-
lines and compared them based on the 32 key guideline features developed by
Hjelmgren et al. RESULTS: No relevant differences were found between the Hun-
garian and the European guidelines in tha major part (23) of the key features. The
Hungarian guideline represented nearly the same methodological aspects for ex-
ample in the choice of comparator, time horizon, discount rate and financial im-
pact analysis. We appraised relevant differences in the perspective of the PE stud-
ies, preferred analytical technic (CMA, CEA, CUA, CBA), systematic review of
evidences, costs to be included, preferred outcome measure and deliver utility. The
QALY is the preferred health outcome measure in cost utility studies almost in
every European countries, however only the English and Scottish guidelines re-
quire only EQ-5D profile to deliver utility. In the new version of the Hungarian
guideline the discount rate will be changed from 5% to 3,7%, the cost-effectiveness
threshold will be explicitly determined (twofold and threefold of GDP per capita)
and the direct comparisons will be preferred instead of indirect comparisons.
CONCLUSIONS:Generally we concluded that the Hungarian guideline published in
2002 and also the new modified version basicly require the same approach and
expectations as the European ones. Change in three main things (discount rate,
cost-effectivess threshold, direct comparison preference) makes our guidelines
more elaborated that could help the rational decision-making. The explicitly de-
termined cost-effectiveness threshold requires specification in the method of de-
livering utility in the future.
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OBJECTIVES: Swiss Health Technology Assessment (HTA) initiatives have been
fragmented, and official HTA processes by the Federal Office of Public Health
(Bundesamt fuer Gesundheit, BAG) have been limited to new technologies and
impaired by the absence of a clear-cut separation of assessment and appraisal.
METHODS: Therefore, santésuisse (the national association of sick funds) and In-
terpharma (representing the interests of the Swiss research-based pharmaceutical
industry) initiated “SwissHTA”, a transparent and inclusive project designed to
develop a national consensus how Switzerland might better use HTAs. The process
was led by a project team, with membership from santésuisse (and Helsana), In-
terpharma (and Roche), the Swiss federal government (BAG), the Swiss Medical
Association (FMH), and the Swiss Academy of Medical Sciences (SAMW). After
seven retreats of the project team and three workshops in the course of 12 months,
the team reached a consensus. RESULTS: The Swiss HTA consensus statement
emphasizes the need for a broad technology focus (covering both new and existing
ones by specific approaches following a common set of core principles) and recom-
mends opportunities for stakeholder involvement throughout the HTA processes.
Primary evaluation criteria should be determined by the social preferences of the
Swiss population, constrained by a prior normative commitment in line with con-
stitutional provisions and the principled, rights-based legal tradition of Switzer-
land. The full range of health-related benefits should be evaluated, and assessment
of clinical evidence should take into account the level of evidence that can reason-
ably be expected in a given context, rating the degree of confidence in outcomes in
relation to the relevance and the magnitude of the effects observed. Economic
viability should be evaluated based on budgetary impact and cost benefit ratios,
whereas the consensus rejects the idea of uniform cost per QALY benchmarks.
CONCLUSIONS: The Swiss HTA consensus combines a pragmatic approach with
well-defined evolutionary options.
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OBJECTIVES: HTA has the increasing role in decision-making process in new EU
member states. Health care systems miscellaneousness causes differences in HTA
exploitation and its characteristics. Our objective was to make an overview of HTA
within these countries to show similarities and its differences. METHODS: Litera-
ture search was done on governmental and governmental like sites to find HTA
related Acts, regulation, guidelines or other relevant documents which describes
HTA country specific approach in new EU member states. First search was relevant
to presence of HTA. In those of them where HTA is defined in legislation we com-
pared several characteristics: model, role, type of HTA, role of pharmacoeconomic,
threshold, discounting factor, sensitivity analysis and differentiation of ap-
proaches between therapeutic and prophylactic approaches. RESULTS: Out of 12
new EU member states (accessed in May 2004 or later) 10 applies HTA, 8 as light
version, 2 as robust NICE like version. HTA has impactful position in 5 of them
(Poland, Slovenia, Slovakia, Estonia and Latvia). Only Poland applies full HTA ap-
proach. Rest of countries use narrow pharmacoeconomic approach. Threshold is
officially published in primary legislation in 2 countries (Poland, Slovakia). Dis-
counting factor varies between 3% and 5%. There was no difference recognized in
evaluation of either therapeutic or prophylactic approaches. CONCLUSIONS: HTA
form and role differ in new EU member states, but some similarities were identi-
fied. These similarities cannot presume any transferability of HTA decision, as it
depends on the other factors like health care system, composition of costs and
methods of its reimbursement by different bodies within relevant country. But
certain common areas for cooperation could be established based on that.
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OBJECTIVES: Patient registries are an important tool for many types of clinical
research, including studies of comparative effectiveness, cost effectiveness, treat-
ment patterns, patient outcomes, and natural history of disease. Use of registries is
increasing, but there is no central database in the U.S. designed specifically to list
patient registries. A searchable public database that is designed to provide infor-
mation about patient registries would support research collaborations, reduce re-
dundancies, encourage the efficient use of resources, and improve transparency in
observational clinical research. The goal of this project, funded by the Agency for
Healthcare Research and Quality, is to design and develop a Registry of Patient
Registries (RoPR) system that meets the needs of a diverse set of stakeholders.
METHODS: Stakeholders from a broad range of organizations and with varying
levels of familiarity with patient registries were identified and invited to participate
in a series of remote and in-person meetings to gather and refine the RoPR system
requirements. Requirements were also revised through public comment and us-
ability and pilot testing. Over 320 individuals participated in RoPR design activities.
RESULTS: Stakeholders identified a range of challenges facing the RoPR system.
Challenges include improving understanding of the distinction between observa-
tional studies, patient registries, and other types of clinical research; determining
how to provide useful information to assess registry quality; ensuring that registry
listings are sufficiently complete; and motivating registry sponsors to list their
registries in a voluntary system. CONCLUSIONS: In response to stakeholder feed-
back, the RoPR was designed as an integrated system with ClinicalTrials.gov that
collects information on registry purpose, classification, objectives, data collected,
progress reports, and interest in collaboration and data sharing. Some challenges
identified through stakeholder discussions were addressed in the system design.
Other challenges must be addressed through education and collection of stake-
holder feedback following the RoPR launch in September 2012.
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OBJECTIVES: Disability is a global public health priority strongly related to socio-
economic status (SES). Social capital (SC) is a complex construct and little is known
about how it relates to SES and disability in a middle-income country. This study’s
purpose was to explore this relationship in Chile. METHODS: Cross-sectional anal-
ysis of Chilean National Health Survey-2010 (n5037). Health outcome: Composite
index of disability (continuous variable, range 0-100). Dependent variables: a) SES
measures: household income per capita (tertiles), educational level (primary/sec-
ondary/higher), employment status (yes/no), and household assets index (tertiles).
b) SC dimensions: interpersonal trust (3 variables), financial/emotional support (2
variables) and social participation (2 variables). After factor analysis, s 2 factors
explained 60% variance (low uniqueness in all variables), with exception of social
participation which was assess separately. After orthogonal-varimax-rotation, 2
continuous aggregated variables were considered for analysis: trust and social sup-
port. Kaiser-Meyer-Olkin0.62; Cronbach alpha0.64 and 0.78 for trust and social
support, respectively. c) Demographic factors: age, sex, marital status, rural/urban
Weighted multiple linear regression models analyzed in R. Confounding and mul-
tiple interactions terms were explored. RESULTS: Mean of disability was 18.8pts. A
significant crude association between disability and SES was observed. All dimen-
sions of SC were significantly associated with disability (Trust: 7.6pts, Support:
10.7pts, Participation:2.0pts). Adjusted regressions showed SES reduced the
magnitude of its association to disability by 70% when dimensions of SC were
added to the model, but remained significant. Social participation lost statistical
significance in presence of SES. Multiplicative interaction terms were found be-
tween SC and education, providing additional higher chance to be disabled when
being poorly educated and having low trust and support. CONCLUSIONS: There is
a complex relationship between disability, SES and SC. Interactions between SES
and SC significantly modify the chance of being disabled and this needs further
consideration in the context of a middle-income country.
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OBJECTIVES: To assess the associations between body mass index (BMI), leisure
time physical activity (LTPA) and health-related quality of life (HRQL) trajectories
among adults. METHODS: Data were drawn from the Canadian National Popula-
tion Health Survey, with respondents being interviewed every two years between
1996/97 and 2006/07. Using growth curve modeling, HRQL trajectories for individ-
uals aged 18 and over were associated with measures of BMI and LTPA. Growth
models were conducted separately for males and females. RESULTS: Findings sug-
gested that, for males, BMI categories had little impact on baseline HRQL, and no
impact on the rate of change in HRQL as men aged. Among women, higher BMI
categories were associated with significantly lower baseline HRQL. However, BMI
had no impact on the rate of change of HRQL. In contrast, LTPA had significant
impacts on baseline HRQL, as well as the rate of change in HRQL, with individuals
who were inactive or sedentary having much steeper declines in HRQL as they
aged, as compared to individuals who were active in their leisure time. This was
true for both men and women, regardless of BMI category. CONCLUSIONS: The
results underscore the importance of LPTA in shaping trajectories of HRQL.
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OBJECTIVES: To analize the relationship between the economic performance and
the epidemiological transition in Mexico for the period from 1985 to 2008
METHODS: Data on Gross State Product (GSP) per capita and Gross Domestic Prod-
uct (GDP) per capita were drawn from both unofficial and official sources, while
mortality data by causes were extracted from vital statistics. Causes of death were
grouped in communicable and non communicable diseases, excluding cancer be-
cause of the infectious etiology of some types of cancer. The epidemiological profile
at state level was measured by dividing the mortality rate by communicable dis-
eases between the mortality rate by non communicable diseases. So a value
greather than one of this ratio reveals a predominance of communicable diseases
and hence an epidemiological lag. Scatter plots and correlation coefficients were
used to analize the data. RESULTS: Throughout the study period a negative corre-
lation was observed between the GDP per capita and the mortality rate by commu-
nicable diseases, while a positive correlation was observed between the GDP per
capita and the mortality rate by non communicable diseases. On the other hand,
the correlation between the epidemiological profile at state level and the GSP per
capita for 1985 was negative but moderate (r  0.53), but for 2008 the correlation
between the same variables almost disappears (r0.029).CONCLUSIONS: For the
whole country the relationship of both time series suggests interactions between
economic performance and mortality by causes, but within the country the results
reveal convergence of mortality running independently of economic performance.
This evidence may support the design of public policies to reduce inequalities in
health.
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OBJECTIVES: To examine the socioeconomic inequalities regarding the self-rated
health status in 2006 and in 2011. Thus, a comparison between the findings will
highlight the changes concerning this topic in times of economic crisis.METHODS:
The research is based on two cross-sectional surveys, which took place in 2006 and
in 2011, and the sample size was 4003 and 6569 respectively. Moreover, a random,
stratified sampling was applied in both cases, which took into account the age, the
gender, the urbanization rate and the geographical region. RESULTS: Initially, the
self-rated health status was measured with a Likert scale (1: very bad, 2: bad, 3:
moderate, 4: good, 5: very good). However, it was dichotomized into two major
scales (0: very bad, bad and moderate, 1: good and very good), in order to facilitate
the methodology. Afterwards, the Concentration Index (Ranking Variable: Income)
was estimated at 0.08 in 2006. The same procedure was repeated in 2011, and the
new Concentration Index was approximately 0.07. CONCLUSIONS:Despite the fact
that the small positive values of this index (which approximate the zero) do not
indicate important inequalities, there are some key conclusions concerning these
findings. Specifically, it is noteworthy that the high-income people seem to have a
higher health status. In addition, the decrease of the Concentration Index in 2011
highlights the impact of economic crisis on health status of middle and upper class.
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OBJECTIVES: A high proportion of patients consume pharmacological resources
during a hospital admission but little is known about the characteristics of those
not receiving a drug prescription (DP).The aim was to assess independent patient’s
factors related to a non-DP during admission. METHODS: Retrospective observa-
tional study including all patients admitted in a teaching hospital during 2010.
Exclusion criteria: direct admission at the Intensive Care Unit. Data collected: pa-
tients with and without a DP , demographics, programmed or urgent admission,
Charlson score, length of hospital stay (LOS), type of Drug Related Group (DRG)
(medical or surgical), DRG weight, readmission, mortality. Statistical analysis: Uni-
variate analysis were performed, using Chi-Square test, Fisher exact Test and
Mann-Whitney U test. A binary logistic regression was applied to identify indepen-
dent factors and the model was assessed with the area under the receiver operating
characteristics (ROC) curve (AUC). RESULTS: Patients: 16,485. Included: 15,750.
Without a DP: 1,822 (11,6%) . Univariate: Patients with and without a DP; Age: 55,40
(24,26) vs 23,70 ( 29,8)(p0.001); Male: 6830(49.0%) vs 972(53.3%)(p0.001). Ur-
gent admission: 5,183(37.2%) vs 1,334(73.2%)(p0.001); Charlson (0): 7,724(51.1%) vs
1,522(83.5%)(P0.001). LOS: 8.18 (10.00) vs 1.67(1.63)(p0.001), medical DRG:
8,743 (62.8%) vs 1,529(83.9%)(p0.001); DRG weight: 1.79(1.70) vs 0.84
(1.55)(p0.001); Readmission: 3.786(27.2%) vs 194(10.6%)(p0.001); mortality:
383(2.7%) vs 47(2.6%)(p0.675). Independent factors related to non-DP: age  18
years (OR: 8.338, CI95%: 7.123-9.760, p0.001), Urgent admission: (OR: 4.830, CI95%:
4.172-5.592, p0.001), Charlson 0: (OR: 1.625, CI95%: 1.372-1.925, p0.001), LOS  2
days (OR: 13.711, CI95%: 11.701-16.066, p0.001), medical DRG: (OR: 2.772, CI95%:
2.354-3.264, p0.001). AUC: 0.917 (CI95%: 0.910-0.924, p0.001). CONCLUSIONS:
Paediatric population, an urgent admission, a low comorbidity status, a short LOS
and a medical DRG were independent factors related to a non-DP during hospital
admission. These patients could be managed in an ambulatory setting, what would
help to reduce the economic burden in hospitals.
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OBJECTIVES: Health care costs are often estimated using self-reported health care
utilization data. The validity of these estimates is, however, challenged by the
validity of self-reported data. The objectives were: (1) to review research findings
on the validity of self-reported health care utilization focusing on factors affecting
it; (2) to delineate implications for future research. METHODS: A systematic liter-
ature search was conducted in relevant literature databases. The identified publi-
cations were screened by predefined inclusion and exclusion criteria. Information
on the accuracy of self-reported health care utilization was extracted from all
included publications and analyzed. RESULTS: Te accuracy of self-reporting varies
strongly across different types of resource use. Underreporting appears to be the
most common problem and increases with the frequency use and length of recall
period. Comparisons across studies are difficult because of substantial heteroge-
neity in study populations, measurement methods and validation approaches
(“gold standard” used, definition of agreement between self-reports and other data
sources). Most identified validation studies are characterized by non-experimental
designs. Consequently, the influence of modifiable attributes of data collection (e.g.
recall period) on the accuracy of self-reported data can only be analyzed by com-
parison among different studies. CONCLUSIONS: More experimental studies are
needed to better quantify the impact of modifiable attributes of data collection,
such as for example different recall periods and modes of questionnaire adminis-
tration, on quality of self-reported health care utilization.
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OBJECTIVES: Irrational prescribing is a usual practice in developing countries like
Pakistan. To analyze the prescribing pattern including both the layout of prescrip-
tion and types of drugs prescribed by the doctors in a government teaching hospital
in Pakistan. METHODS: Prescriptions (n  830) from a government teaching hos-
pital were collected randomly over a period of three months and evaluated retro-
spectively. The data were analyzed to assess the quality of prescription including
both the layout and types of drug prescribed following the guidelines of WHO.
RESULTS: Assessment of prescriptions revealed that the quality of layout of the
prescriptions was unsatisfactory. Clarity of written instructions on how to take the
medicines was inadequate. 41% of the prescriptions were without the age of the
patient which includes 23% of pediatric prescriptions. Thirteen percent (13%) of
medicines were prescribed with their uncommon abbreviated names. The average
numbers of drugs per prescription were found to be 3.57. Seventy seven percent
(77%) of the drugs were prescribed with their generic names. Polypharmacy was the
norm, with more than half (53.9%) of the prescriptions containing at least 3 medi-
cines. Twenty eight percent (28%) of prescriptions included vitamin preparations
and 33% of analgesics/antipyretics. Penicillins, Cephalosporins, Quinolones Metro-
nidazole and Tetracyclines were commonly prescribed antimicrobials, respec-
tively. The high-priced antimicrobials were frequently prescribed without culture
and sensitivity studies. CONCLUSIONS: This study concludes that quality of pre-
scriptions in terms of layout and content of the drugs prescribed is inadequate
requiring continued medical education. To enhance the legibility computer gener-
ated prescriptions should be promoted.
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